CLBT (Cellebrite DI) 5-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLBT Cellebrite DI Ltd CLBT
81 GF Score
Price $11.63
GF Value $16.32
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Cellebrite DI 5-Year EBITDA Growth Rate?

Cellebrite DI CLBT +2.92% 81 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates CLBT with a GF Score™ of 81/100 and a GF Value™ of $16.32 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Cellebrite DI's EBITDA per Share for the three months ended in Jun. 2026 was $0.06.

During the past 3 years, the average EBITDA Per Share Growth Rate was -14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cellebrite DI was 181.10% per year. The lowest was -14.80% per year. And the median was 83.15% per year.

Cellebrite DI  (NAS:CLBT) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Cellebrite DI 5-Year EBITDA Growth Rate Related Terms

CLBT vs TENB, PAY, BLSH: 5-Year EBITDA Growth Rate Comparison

For the Software - Infrastructure subindustry, Cellebrite DI's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cellebrite DI 5-Year EBITDA Growth Rate vs Software Industry

For the Software industry and Technology sector, Cellebrite DI's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cellebrite DI's 5-Year EBITDA Growth Rate falls into.


CLBT
81GF Score
Cellebrite DI Ltd CLBT
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellebrite DI 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Cellebrite DI (CLBT) has a 5-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Cellebrite DI and its competitors.
Is Cellebrite DI's 5-Year EBITDA Growth Rate too high?
Cellebrite DI's current 5-Year EBITDA Growth Rate is 0.00%. Overall, Cellebrite DI has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cellebrite DI's 5-Year EBITDA Growth Rate compare to TENB and PAY?
Cellebrite DI's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Software company?
A good 5-Year EBITDA Growth Rate depends on the Software industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Cellebrite DI and its competitors. Cellebrite DI's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellebrite DI stock overvalued right now?
Based on GuruFocus' analysis, Cellebrite DI (CLBT) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.32, compared to a current price of $11.63 — trading 28.7% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. Cellebrite DI's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Cellebrite DI (CLBT), the current 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cellebrite DI (CLBT) Overvalued in 2026?

Based on GuruFocus' analysis, Cellebrite DI stock appears to be undervalued. The current stock price of $11.63 is trading 28.7% below its estimated GF Value™ of $16.32. GuruFocus considers Cellebrite DI to be Modestly Undervalued.

Key valuation signals for CLBT:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: $16.32 vs. price of $11.63 (28.7% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the CLBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cellebrite DI Business Description

Other Exchanges 9W9:Germany
Address 94 Shlomo Shmelzer Road, P.O. Box 3925, Petah Tikva, ISR, 4970602
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
81GF Score

Get the complete analysis for CLBT

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.63
Price
$16.32
GF Value